Manufacturer record
Rivpra Formulations Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Rivpra Formulations Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between March 2020 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Rivpra Formulations Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sodium Bicarbonate Tablets USP 1000mg | T-2406004Mfg 2024-06 · Exp 2026-05 | Sample Shows Category of Tablets (Capping and Brittleness) as described under DCC Guidelines on NSQ Drugs approved in 1993.Other | DTL ThrissurState lab | Feb 2026 |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L2502010Mfg 2025-02 · Exp 2027-01 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L2502007Mfg 2025-02 · Exp 2027-01 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Panboon [Pantoprazole Gastro-Resistant Tablet IP | T-2402172Mfg 2024-02 · Exp 2026-01 | It fails the test ?Dissolution? stated in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Nov 2024 |
| Paracetamol Paediatric Oral Suspension IP 125 mg/5 ml (STARMOL SUSPENSION) | RV19007Mfg 2019-11 · Exp 2021-10 | AssayAssay | RDTL ChandigarhState lab | Mar 2020 |
| JFIX-LB (Cefixime Trihydrate with Lactic Acid Tablets IP) | HS.114Mfg 2019-09 · Exp 2021-08 | Identification of CefiximeIdentification | CDTL MumbaiCDSCO lab | Mar 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.